Quick ReadPlain-language overview · read this first
This is a Japanese company called Harmonic Drive. It makes the precision “reducer” inside robot joints, the core part that lets a motor deliver force steadily and accurately. It has more than 70% of the global high-end market. The report’s stance is clear: the company is excellent, but the current price is far too expensive. The rating is “Watch,” with a suggestion to consider it only below ¥3,200.
Its most valuable capability is the materials and process expertise built up over decades. In fields such as aerospace and semiconductors, where failure is not acceptable, customers almost exclusively trust it. But this expertise is not protected by a patent lock. Chinese manufacturers are catching up quickly at roughly half the price and have already taken enough share that Harmonic Drive’s China share is down to a little over 30%.
Now look at profits. The company is currently in an industry trough, earning only a little over one-tenth of what it made in its best year. Yet even if profits are adjusted back to a normal year, buying the whole company at today’s price would still take more than a hundred years to earn back the purchase price. That is absurdly expensive. The share price has already risen about 4x from its low two years ago, sits above every expert target price, and one analyst even sees about 60% downside.
The biggest risk is that about 70% of today’s price is a bet on the humanoid robot boom. But the largest part of that opportunity may well be taken by lower-priced Chinese competitors. Harmonic Drive’s own share may get smaller, and less profitable. In short: good company, bad price.
The above is only an explanation of this report, not investment advice. The stock market involves risk; invest with caution.
LeadHarmonic Drive Systems (6324.TSE) is the global leader in harmonic reducers, or strain wave gearing, with roughly 58% global share by sales value and more than 70% share in the high-end market. Its products are de facto standard components for industrial robot wrist and forearm joints, semiconductor equipment, aerospace precision axes, and the purest picks-and-shovels exposure to humanoid robot rotary joints. Research rating Watch: a great company at an uninvestable price, with real but eroding moat quality and negative margin of safety.
Research Perspective Statement
This report applies the Zen Horizon Framework to Harmonic Drive Systems Inc. (Tokyo Stock Exchange 6324, EODHD code 6324.TSE), combining horizontal peer benchmarking with vertical company-history analysis. Currency is Japanese yen (JPY), and fiscal years are labeled by fiscal year-end month and year. Japan's fiscal year ends in March, so "FY3/2026" refers to the fiscal year ended March 2026 and was released on 2026-05-13. Note that some overseas data vendors label that year as "FY2026," creating a one-year mismatch. All price and valuation data are based on the 2026-06-05 close and sources are marked independently.
Entity clarification, verified: the subject of this report is the listed Japanese parent company Harmonic Drive Systems (6324, consolidated reporting basis). ① It is entirely unrelated to Harmonic Inc. in the United States (NASDAQ:HLIT, video/broadband equipment); the English names are merely similar. ② Germany's Harmonic Drive SE (Limburg) is a 100%-owned subsidiary of 6324. It was consolidated after the 2017 stake increase and became a wholly owned subsidiary in 2021. It was the entity behind the large 2024 impairment and is not an unrelated third party. ③ It has no equity relationship with Japan's Nidec (6594). Nidec is not on the shareholder register, and its Nidec Drive Technology unit is instead a competitor in the harmonic reducer market. The true controlling parent is the Ito family's KODEN Holdings, with roughly 35% ownership.
This report does not constitute investment advice. Forward-looking judgments involving humanoid robot TAM, shipment forecasts, and future share are marked as forecasts with institutional sources where possible. Key figures have been independently red-teamed twice; where conflicts remain, both values are shown with a ⚠️ marker.
1. Conclusion First
Rating: Watch, leaning bearish. Ideal buy price ≤ ¥3,200.
One-sentence view: a great company at an uninvestable price. The global harmonic reducer leader has a real but "eroding" moat (3/5) that deserves close tracking, but the current price has extremely over-discounted a humanoid robot supercycle, while the largest upside pool may be intercepted by half-price Chinese suppliers. The margin of safety is negative.
Core logic chain:
A real moat, but an "eroding" one (3/5). Harmonic Drive Systems is the absolute global leader in harmonic reducers, with roughly 58% share by value and more than 70% share in the high-end market. The real barriers lie in decades of materials expertise, including special steel supplied by Japan Steel Works, gear-grinding precision, fatigue life, and miniaturization know-how. HarmonicDrive® is almost synonymous with the category, and the company is close to a sole supplier in high-end aerospace, semiconductor, and medical uses. But the foundational patent (Musser 1959) expired long ago, there is no IP gate protecting the moat, and China's Leader Harmonious Drive continues to erode share with Japanese-series pricing at a 40-60% discount plus fast technological convergence. China's domestic penetration rate reached 75.1% in 2024, while Harmonic Drive Systems' China share fell to roughly 35.6%.
The balance sheet is solid, and business quality is far better than prior "option/bad business" cases. The equity ratio is 72.2%, net cash is roughly ¥3.6 billion, and even in the heavy-loss year of 2024, operating cash flow remained positive at +¥12.7 billion. This is a cash-generative cyclical leader that can survive a winter cycle, not a cash-bleeding company. Its quality is far better than Canaan (Avoid) and RXRX (Watch, unprofitable option).
Earnings are at the cycle trough, so 417x is a low-E distortion. The latest FY3/2026 revenue was ¥59.56 billion (+7.0%), operating profit only ¥2.57 billion (4.3% margin), net income attributable to owners of the parent ¥1.61 billion (-53.7%), and EPS ¥16.99. Current EPS is only 14% of the historical peak of ¥117.6. But even if earnings are normalized to mid-cycle EPS of roughly ¥65-85, PE remains 85-110x; using the strongest historical earnings still gives 60x. The cycle explains the optical PE distortion, not the valuation itself.
Valuation is extremely over-discounted, and the current price is above every sell-side average target. The current price of ¥7,090 is roughly 4 times the 2024 bottom of ¥1,763, up +123.31% over the past year, with forward PE of 116x (149x on guidance), PB of 8.35x (about the 94th percentile of the 16-year range, close to the 2020 historical peak). The current price is already above all sell-side average targets. The core cluster is roughly ¥5,300, implying the stock is about 19-38% above it. Jefferies cut the stock to Underperform with a ¥2,400 target in 2026-02, the only bear call and implying -66%. SWS DCF fair value is only ¥2,358. Roughly 70% of market capitalization is a humanoid robot option.
The largest growth dividend may go to Chinese suppliers. For Tesla Optimus, the largest potential buyer, the main incremental harmonic reducer supply has gone to China's Leader Harmonious Drive, with an exclusive Mexico factory, roughly 10,000 sets delivered in 2025, a target of about 60% share, and unit prices roughly halved. Harmonic Drive Systems has not been cleared out and still defends high-end dual sourcing, but the dynamic is "the pie gets larger, its slice gets smaller, and gross margin is pressured." Harmonic reducers are used only in upper-limb rotary joints, about 14 per unit, while high-torque lower-limb joints use planetary roller screws, structurally capping harmonic content per unit at about 7% of BOM.
Why not "Avoid": this is a real global leader, with genuine pricing power, real technical barriers, net cash, and a history of cash earnings at the trough. Its business quality is far above bad businesses such as Canaan. Calling for structural zero would be too harsh on the business itself.
Why not "Hold/Buy": the moat is real but is being structurally eroded by half-price Chinese supply. It is neither broad enough nor durable enough. Margin of safety is negative. The current price is above every sell-side average, forward PE is 116-149x, PB is near the historical top, and DCF/bear targets point to -66%. Risk-reward is highly asymmetric: downside to the sell-side average is about -25%, downside to DCF/Jefferies is about -66%, while upside requires a major beat in the humanoid narrative plus Harmonic Drive Systems simultaneously holding back half-price Chinese competitors. At 116-149x, that is a low-probability combination.
【Valuation Range】(JPY): current price 7,090; bear 2,300-3,200 (cycle not recovered + humanoid dividend goes elsewhere, reverting to DCF/52-week low/Jefferies); base 3,200-4,800 (normalized mid-cycle earnings + partial share retention); bull 6,000-9,500 (humanoid volume ramp + cycle recovery + share retention, challenging the 2020 historical high of ¥9,510). The current price is already inside the bull range. The market is pricing today as if the humanoid supercycle has succeeded. Ideal buy price ≤ ¥3,200.
2. Company Profile
Core business and products. Harmonic Drive Systems is a single-business company focused on precision reducers and related application products. It reports under two major categories, based on FY3/2026 external sales:
| Product category | Revenue (¥mn) | Share | Content |
|---|---|---|---|
| Speed reducers | 46,334 | 77.8% | HarmonicDrive® strain wave gearing (core), precision planetary gearheads, cross-roller bearings |
| Mechatronics products | 13,224 | 22.2% | Rotary/linear actuators, servo motors, gearheads, sensors/encoders, control equipment |
Revenue structure. By destination: Japan about 41%, Europe about 28%, North America about 20%, China about 7%, and others about 4%. Overseas revenue is about 59%, making this essentially a globalized Japanese company. The wholly owned German subsidiary is the largest single overseas production and sales base. By downstream application, on the parent standalone basis in FY3/2025: industrial robots about 40%, automotive about 19% (almost entirely Nissan, the largest customer, about ¥5.73 billion in FY3/2025 and 10.3% of consolidated revenue; from FY3/2026 no single customer reached 10%, lowering concentration), semiconductor manufacturing equipment about 14%, and aerospace about 11%.
Business model essence: selling a core component regarded by global robots and precision equipment as a de facto standard. This is a typical picks-and-shovels business, with the company's own positioning as "Total Motion Control." Orders are built to order. FY3/2026 consolidated order intake was high at ¥61.6 billion (+16.2%), exceeding sales of ¥59.6 billion, with book-to-bill above 1 and order replenishment underway. Its near-monopoly position gives it pricing power. In FY3/2026, the company explicitly cited improved profitability through product price increases and cost innovation.
Operations. Headquarters are in Shinagawa, Tokyo. Main production capacity is in Nagano Prefecture (Hotaka/Ariake/Matsumoto/Toyoshina/Komagane), plus Limburg in Germany and Beverly in the United States. Shanghai, China is sales only. Tangible fixed assets are mainly in Japan, about ¥30.0 billion, making the business capital-intensive. Consolidated employees were about 1,349, based on the 2024-03 disclosure.
Capital and governance. Listing path: OTC registration (1998) → JASDAQ (2004) → TSE Standard (2022) → TSE Prime (2026-02 transfer, one identity catalyst for the latest rally). The controlling parent is KODEN Holdings, controlled by the Ito family, with roughly 34.8-35.3% ownership, originating from the 1989 merger into KODEN Electronics. The second-largest individual shareholder, Norimitsu Ito, owns about 3.16%, and family-related holdings total about 38%. The family has effective control through the parent company, but below 50%. Nabtesco still owns about 5%, a legacy of the 2005 U.S. joint venture. Foreign institutions, including Norway's sovereign wealth fund, UBS, Morgan Stanley, Goldman Sachs, and State Street, are meaningful holders, but each individual stake is below 3%. There are no dual-class shares or super voting rights. Outside independent directors are 5/10. President Akira Maruyama, a professional manager who joined in 1985 and took office in 2024-06, has publicly sounded cautious about humanoid robot investment. Capital policy: target payout ratio of 35%; FY3/2026 DPS was ¥20 despite trough earnings, implying a payout ratio of 117.7%, supported by net cash and positive cash flow. The medium-term plan targets FY2030 revenue of at least ¥100.0 billion, operating margin of at least 15%, and ROE/ROIC of at least 10%.
3. Vertical Analysis
Company history. In 1955, U.S. inventor C.W. Musser created the strain wave gearing principle, initially designed for aerospace. In 1970, Hasegawa Gear Works and U.S. company USM formed a joint venture to establish the company and localize the technology in Japan. HarmonicDrive® became a trademark. In 1989, the company was absorbed into KODEN Electronics and became its subsidiary, explaining the current control structure. From 1996, it cooperated with Germany's Harmonic Drive GmbH, now SE; in 2017 it increased its stake in the German company to 74.7% and consolidated it; in 2021 it made both the German SE and U.S. LLC 100% owned. It moved to TSE Standard in 2022 and to TSE Prime in 2026-02. Strain wave gearing has long been used in space mechanisms, where light weight and high precision are must-haves, semiconductor equipment, and Honda's ASIMO biped robot. Humanoid robots are the latest growth vector.
Long-term revenue and profit trajectory, highly cyclical with two peaks and two troughs:
| Fiscal year (March year-end) | Revenue (¥bn) | Operating profit (¥bn) | Net income attributable to owners (¥bn) | Operating margin | EPS (¥) |
|---|---|---|---|---|---|
| FY3/2019 (peak) | 67.81 | 16.90 | 11.30 | 24.5% | 117.62 |
| FY3/2021 (trough) | 37.03 | 0.87 | 0.66 | 2.3% | 6.88 |
| FY3/2023 (record revenue) | 71.53 | 10.22 | 7.60 | 14.3% | 79.67 |
| FY3/2024 (large loss) | 55.80 | 0.13 | -24.81 | 0.2% | -261.0 |
| FY3/2025 | 55.65 | 0.007 | 3.47 | 0.0% | 36.57 |
| FY3/2026 (latest) | 59.56 | 2.57 | 1.61 | 4.3% | 16.99 |
| FY3/2027 (company guidance) | 68.00 | 6.20 | 4.50 | 9.1% | 47.54 |
Revenue fluctuates sharply with factory automation and semiconductor equipment capex, with peaks and troughs nearly 2 times apart. Profit sensitivity is extremely high: operating profit was ¥10.0-16.9 billion in boom years, then collapsed toward zero or losses in downturn years. Note that the FY3/2024 net loss of -¥24.8 billion came from a one-off impairment of ¥28.16 billion at the German subsidiary (discussed in the financial review), the core event behind the simultaneous bottoming of earnings and the stock price in 2024.
Stock price history, all dates marked, no split, historical prices directly comparable with today:
All-time high since listing was ¥9,510 on 2020-12-28. Yet performance was at a trough then, with FY3/2021 net income only ¥0.66 billion. It was a valuation top driven by theme/recovery expectations.
The 2021-2024 long bear market followed two cyclical downturns plus the German impairment. The stock hit a multi-year bottom of ¥1,763 on 2024-11-14, in sync with the FY3/2024 heavy loss.
2024-2026 humanoid robot theme surge: the stock moved from the ¥1,763 bottom to ¥5,350 in 2025-02, then fell to ¥2,316 in 2025-09, the 52-week low, before a one-way short squeeze in May 2026. It touched an intraday 52-week high of ¥8,400 on 2026-05-27. Catalysts included the transfer to TSE Prime in 2026-02, FY3/2026 earnings turning operating-profit positive, orders reaching a four-year high, the 2026-2030 plan, and the industry-wide theme of Tesla Optimus nearing mass production.
After the peak, it pulled back and closed at ¥7,090 on 2026-06-05. From the ¥1,763 bottom to ¥8,400 was +376%, over about 18 months. Still, ¥8,400 remained about 12% below the 2020 all-time high of ¥9,510. The ¥8,000-8,400 band is a strong resistance zone that capped the stock in early 2018 and again in 2026.
Historical valuation position: trailing PE of 417x is distorted by trough earnings. The cleanest valuation anchor is PBR of 8.35x, about the 94th percentile of the 2010-2026 range of 0.91-8.9x and close to the historical high, corresponding to the 2020 major top. On book value multiples, valuation has returned to near historical top levels.
Vertical summary: a typical trough earnings × top valuation mismatch. Fundamentals are in the early-cycle phase of lifting off from the cycle bottom, with FY3/2027 guidance pointing to operating profit +141%, but the stock has already been pushed by the humanoid theme to a valuation level close to the 2020 historical peak.
4. Financial Review
A strong cycle plus a one-off large impairment drove profit to the trough. Revenue swung from a ¥37.0 billion trough to a ¥71.5 billion peak, nearly 2 times. Operating profit collapsed from a ¥16.9 billion peak in FY3/2019, with 24.5% operating margin, to near zero in FY3/2024 at ¥0.13 billion and in FY3/2025 at only ¥0.007 billion, before recovering to ¥2.57 billion in FY3/2026, a 4.3% margin. Structural gross margin compression: peak gross margin fell from 45-47% in FY3/2017-2019 to 36-39% at the recent cycle peak, and then to the current 30.5%. Consolidating Germany's HD SE pulled down group-wide profitability.
FY3/2024 impairment of ¥28.16 billion, causing a -¥24.8 billion net loss: components were goodwill ¥15.25 billion, customer-relationship intangible assets ¥10.19 billion, and technology assets ¥2.72 billion. The target was Germany's Harmonic Drive SE, consolidated in 2017. European industrial robot demand failed to meet the acquisition plan, while customer-relationship amortization consumed operating profit. Key point: this was a one-off non-cash impairment. Ordinary profit that year was still positive at ¥0.57 billion, and the balance sheet was cleaned up as goodwill/intangibles were sharply written off, reducing future impairment risk.
Is 417x a "low E" or a "high P" problem? Current EPS of ¥16.99 is only 14% of the historical peak of ¥117.62 in FY3/2019 and 21% of the recent peak of ¥79.67 in FY3/2023. Current operating margin of 4.3% compares with the historical peak of 24.5%. Profit has been squeezed to an extremely low level by the cycle and impairment, making E shrink severely and driving the 417x headline multiple. But normalized anchors are as follows:
| Earnings basis | EPS (¥) | PE at ¥7,090 |
|---|---|---|
| Trailing (FY3/2026 actual) | 16.99 | 417x |
| Company guidance (FY3/2027) | 47.54 | 149x |
| Sell-side consensus (forward) | about 60.8 | 117x |
| Normalized mid-cycle (this report's estimate) | 65-85 | 85-110x |
| Historical strongest earnings (FY3/2019) | 117.62 | 60x |
Judgment: roughly 80% of 417x is distortion from the cycle/impairment trough, but even after normalization, the multiple is still 85-110x, and even the strongest historical earnings imply 60x. The cycle explains why PE looks frightening; it does not justify the valuation itself.
Balance sheet is solid, and the business does not burn cash at the trough. FY3/2026: cash of ¥21.56 billion exceeded interest-bearing debt of ¥18.06 billion, giving net cash of +¥3.62 billion, an equity ratio of 72.2%, and BPS of about ¥849. Operating cash flow has been positive throughout the past 10 years, at ¥6.4-15.1 billion. Even in FY3/2024, the -¥24.8 billion heavy-loss year, operating cash flow was instead the 10-year high at +¥12.7 billion, because the loss was a non-cash impairment plus high depreciation. Free cash flow has remained positive. This is a cash-cow cyclical leader that can withstand a winter cycle, not a cash-bleeding company.
Earnings quality requires layered caution: (i) the FY3/2024 heavy loss was a one-off non-cash impairment; (ii) FY3/2025 net income of ¥3.47 billion came almost entirely below the operating line, while operating profit was only ¥0.007 billion, so quality was low and non-recurring; (iii) the real operating recovery began only in FY3/2026, with operating margin at 4.3%. For 6324, investors must look through to operating margin and avoid being misled by jumps in net income attributable to owners. Countercyclical dividend resilience: DPS has held at ¥20 for years, including the heavy-loss year, and FY3/2027 guidance jumps to ¥42.1. But the current dividend yield is only 0.28%, so dividends are not the investment thesis and provide no yield cushion.
Structural concern: high margin does not mean high ROE. Even at boom peaks, ROE was only about 7-11% and ROIC about 7%, dragged by heavy capital and cash. Financial quality supports the label of "quality leader," but at ¥7,090 the price has already fully discounted a complete cycle recovery plus humanoid volume ramp. Financials do not provide a margin of safety.
5. Moat
Share, by segmented basis, ⚠️ required reading. Harmonic Drive Systems is the undisputed global number one in harmonic reducers, but share varies greatly by measurement basis:
Value/sales basis: global share of about 58% in 2024, using a GGII-related basis.
High-end market basis: more than 70%, led by mini actuators and high precision.
GGII volume basis, units: share is lower and continues to decline. In 2024, global industrial robot harmonic reducer consumption was 1.2187 million units (+21.4%), while China's domestic penetration rate rose to 75.11%.
China market: Harmonic Drive Systems had about 35.6% share in 2024H1, declining.
→ Key wording: global high-end share is above 70%, value share is about 58%, but volume share and China share are being rapidly eroded by domestic Chinese suppliers.
Technical barriers, medium: the core is know-how, not IP. The three-part principle of wave generator + flexspline + circular spline delivers high single-stage reduction ratio, zero backlash, light weight, and compact size. Key point: the foundational patent, Musser 1959, US 2,906,143, expired long ago. This is the fundamental reason Chinese and global competitors can legally manufacture the product, and basic IP is no longer the moat. Current barriers consist of peripheral tooth-profile/process patents that can be designed around, plus real materials and manufacturing know-how: special steel/ductile iron supplied by Japan Steel Works, flexspline fatigue life (fatigue fracture is the main failure mode for harmonic reducers), gear-grinding precision, batch consistency, and miniaturization (Harmonic Drive Systems can make size 3 units, while Leader's smallest is size 5). Real, but not insurmountable. Chinese suppliers have caught up in strength metrics and still lag in precision/life/miniaturization, but they are closing quickly.
Customer certification and brand. In aerospace, semiconductor lithography, medical, and high-end collaborative robots, the company is close to sole supplier. Failure is not an option, and switching costs are extremely high, so the moat is broad. But in general industrial uses and humanoid mass production, OEMs actively nurture Chinese second sources to cut cost, so certification barriers are rapidly diluted. HarmonicDrive® is almost a category synonym and brand equity is strong. Pricing power exists, with Chinese products only 40-60% of its selling price, but it is being eroded by the price gap. Gross margin fell from 39% in FY3/2022 to 30.5% in FY3/2026, while peak operating margin of 22-25% was compressed to nearly 0% in FY3/2025.
Competitive landscape:
Nabtesco, RV reducers, about 60% global share, is complementary rather than a threat: RV reducers are used in heavy-load bases/upper arms, for joints above 20kg, while harmonic reducers are used in forearms/wrists/collaborative robots below 20kg, covering different joints.
Chinese harmonic reducers are the real threat: Leader Harmonious Drive (about 10% global share, about 25% China share and rising, half-price, precision ±30 arc-seconds/life above 10,000 hours already matching strength metrics), Laifual Drive, Shuanghuan Driveline, and others. China's domestic penetration rate reached 75.1% in 2024.
Humanoid robots are the biggest variable, and a double-edged sword: the incremental TAM may be captured mainly by Chinese suppliers at half-price. Leader has already entered the Tesla chain, as discussed in the industry-demand section.
Moat score: 3 / 5, medium, an eroding moat of "broad in high-end, narrowing in mass production." Factors supporting 4-5: absolute global number one, category-synonym brand, near monopoly in high-end with very high switching costs, and decades of materials and manufacturing know-how. Factors dragging it to 2-3: ① the foundational patent has expired, and the moat has no IP gate; ② Chinese suppliers offer half-price products with fast technical convergence, and China share has been lost quickly; ③ earnings are extremely cyclical, with operating margin swinging violently between about 0% and about 25%, showing the moat cannot smooth the cycle; ④ the largest humanoid growth opportunity is likely to be captured mainly by the Chinese supply chain at half price. Durability view: sustainable in high-precision/high-reliability/miniaturized niches; structurally eroding in general industry and the main battlefield of humanoid mass production, with the direction "slow narrowing" rather than expansion.
6. Industry Demand
Traditional base: the cycle bottom has passed, and recovery is in the early stage. The drivers are traditional robots and semiconductors, not humanoids. FY3/2024 bottomed with ordinary loss → FY3/2025 orders +14.3% → FY3/2026 profit recovered and was revised upward during the year, with operating profit lifted from ¥1.5 billion to ¥2.5 billion. External confirmation: SEMI forecasts global semiconductor equipment sales to reach a record $139B in 2026 and $156B in 2027, driven by AI/HBM/DRAM. Harmonic Drive Systems' semiconductor equipment line is pro-cyclical in 2026-2027. This is a higher-certainty traditional recovery, and FY3/2027 guidance for operating profit +141% is a bet on this cycle upturn.
Humanoid robot increment: a real bet, but still mainly an unexercised option.
Per-unit usage and content value: Tesla Optimus has 28 actuators = 14 rotary actuators, including harmonic reducers, plus 14 linear actuators, which use planetary roller screws, not harmonic reducers. High-torque lower-limb joints use roller screws because harmonic reducer life is insufficient. Harmonic content per unit is structurally capped, at about 14 per unit and roughly 7% of whole-machine BOM, not every body joint.
Company action, real capital deployed: it has invested about ¥10.0 billion in dedicated humanoid reducer mass-production capacity at the Ariake plant, targeting FY3/2027 humanoid reducer sales of ¥10.0-20.0 billion, or about 15-30% of total revenue. But FY3/2026 actual growth came from traditional lines, with no visible humanoid volume ramp. Current AI robot orders, including humanoids, are only about ¥2.5 billion on a consolidated basis, or roughly 4% of revenue.
Mass-production timetable keeps slipping: Tesla Optimus has been affected by rare-earth controls and other issues; Gen3 mass production moved to 2026, and high-volume ramp moved to summer 2027. Industry 2026 shipment forecasts range from more than 50,000 units to 900,000 units, a full order-of-magnitude gap (⚠️ no single point estimate should be trusted).
TAM, forecast: Goldman estimates the 2035 humanoid market at $38B. Chinese sources estimate the humanoid harmonic reducer segment at about RMB 11.5 billion in 2030, corresponding to about 660,000 humanoids and per-unit harmonic value of about ¥17,000/about $2,400 under a low-price China basis.
Second derivative of demand: the traditional base is a high-certainty recovery from cycle bottom to early stage. Humanoids are a high-elasticity option with double uncertainty in share and timing. The current order recovery is mainly driven by traditional demand; no public data separately breaks out humanoids.
Key uncertainties (⚠️): Chinese substitution and customer price pressure (Leader targets about 60% Optimus harmonic share in 2026 at half-price); technology substitution (lower limbs use roller screws, while harmonic reducers in rotary joints face cycloidal/planetary competition); mass-production delays; valuation already priced in, with current price above sell-side averages, as discussed in the valuation section.
7. Horizontal Analysis
Peer table, valuation, 2026-06 window:
| Company (ticker/currency) | Market cap ≈ USD | trailing PE | forward PE | PB | PS | Operating margin | Global share position |
|---|---|---|---|---|---|---|---|
| Harmonic Drive Systems 6324.TSE | $4.5B | 417x | 116.6x | 8.35 | 11.27 | 4.3% | Harmonic reducer value share about 58%, high-end >70% |
| Nabtesco 6268.TSE | $4.0B | 37x | 28x | 2.12 | 1.90 | 7.5% | RV reducer global share about 60% |
| Leader Harmonious Drive 688017.SHG | about $8.3B | about 480-519x | about 250-300x (est.) | about 19-20 | about 105 (calculated) | — | Harmonic reducer global share about 10%, China about 25% |
| THK 6481.TSE | $5.7B | 58x | 26.8x | 3.37 | 3.34 | 8.6% | Linear guides/ball screws |
| HIWIN 2049.TW | $3.8B | 80x | 37.6x | 3.26 | 5.03 | 6.8% | Linear guides/ball screws |
| Nabtesco comparison, FANUC/Yaskawa | — | — | 38.6x/29x | — | — | — | Robots/CNC/servos |
vs Leader Harmonious Drive, global leader vs Chinese challenger: Leader is more expensive and more extreme on every valuation dimension. PS is about 105x, roughly 9 times Harmonic Drive Systems' 11.27x, and PB is about 20x, roughly 2.4 times. Decisive contrast: Leader's market cap of about $8.3 billion has overtaken Harmonic Drive Systems' roughly $4.5 billion, despite having only about 1/5 of its revenue and about 1/8 of its global share. Share trend: domestic substitution is real. China's domestic harmonic reducer share rose from 48.7% in 2020 to 75.1% in 2024. The gross-margin gap, Leader 36.6% versus Harmonic Drive Systems 30.5%, is cyclical rather than a structural reversal, since Harmonic Drive Systems' historical gross margin was about 45%+. The growth gap is significant: Leader revenue +47%/net income +122% versus Harmonic Drive Systems nearly flat.
vs Nabtesco, harmonic vs RV twin leaders: Harmonic Drive Systems trades at 417x/116x, PB 8.35x, PS 11.27x, while Nabtesco trades at 37x/28x, PB 2.12x, PS 1.90x. Even after removing Harmonic Drive Systems' earnings distortion and using PB, about 4 times, and PS, about 6 times, Harmonic Drive Systems still carries a systematic premium. Nabtesco also has better current earnings quality, with 7.5% operating margin versus 4.3% and ROIC of 6.1% versus 2.4%. In humanoid elasticity, harmonic reducers are structurally above RV reducers, because lower limbs use roller screws and not RV, so Harmonic Drive Systems/Leader have higher humanoid beta than Nabtesco/Shuanghuan.
Valuation percentile and qualitative view: forward PE ranking: Leader Harmonious Drive (about 250-300x) > Harmonic Drive Systems (116.6x) > FANUC 38.6x > HIWIN 37.6x > Yaskawa 29x > Nabtesco 28x > THK 26.8x > Nidec 10.8x. Harmonic Drive Systems is the most expensive forward multiple in the Japanese transmission chain. The near-doubling of the whole chain over one year, with the two harmonic names +123%/+121% and THK +88%, is theme beta rather than stock-specific alpha. Conclusion: Harmonic Drive Systems is the world's only scaled pure harmonic reducer leader, with the highest humanoid purity and about 100% of revenue from reducers. A scarcity premium is directionally reasonable but overdone in magnitude. Triple expectations, cycle recovery + humanoid volume ramp + share retention, are already priced in simultaneously, leaving thin margin of safety and low tolerance for error. Leader's premium is even more extreme than Harmonic Drive Systems'.
8. Current Fundamentals
Latest results, FY3/2026, released 2026-05-13: revenue ¥59.56 billion (+7.0%), operating profit ¥2.57 billion (4.3% margin), ordinary profit ¥2.54 billion, net income attributable to owners ¥1.61 billion (-53.7%), EPS ¥16.99, ROE 2.0%, gross margin 30.5%, equity ratio 72.2%. Order intake was ¥61.6 billion (+16.2%), book-to-bill above 1, with order replenishment driven by European and U.S. AI robots plus semiconductor equipment. During the period, in 2026-04, full-year operating profit was revised upward from ¥1.5 billion to ¥2.5 billion (+66.7%), because robot and semiconductor manufacturing equipment demand was stronger than expected and utilization rose at Japanese and North American plants.
FY3/2027 guidance, company: revenue ¥68.0 billion (+14.2%), operating profit ¥6.2 billion (+141.5%), net income attributable to owners ¥4.5 billion (+179.7%), EPS ¥47.54, DPS ¥42.1.
Current utilization and capacity: domestic plant utilization is only about 50%. The company says existing equipment can handle demand and no major expansion is currently needed. This is both a cycle-bottom signal and a source of recovery elasticity, since capacity is ready, but it becomes idle-capacity risk if humanoid expectation-driven expansion fails to materialize.
Sell-side consensus and pricing mismatch, key point: analyst rating consensus is Moderate Buy, roughly 5 buys/2 holds/1 sell, but the average target price is about ¥5,300, with a core cluster of ¥5,250-5,415 and a range of ¥2,400-10,000. The current price of ¥7,090 is already about 19-38% above all average-target measures. Jefferies downgraded the stock to Underperform on 2026-02-11 with a ¥2,400 target, the only bear call, implying -66%, citing Chinese competition and valuation exceeding fundamentals. In other words, the current price has overreached to a level not even supported by the optimistic sell-side average.
9. Valuation
Multiple PE lenses: trailing 417x (EPS ¥16.99, trough distortion) / forward 116.6x (consensus EPS about ¥60.8) / 149x (company guidance EPS ¥47.54). ⚠️ Consensus EPS is about 28% above the company's own guidance, meaning the market expects continued guidance beats. Prudence points to the company-guidance 149x as the forward anchor, but regardless of which measure is used, 110-149x is extremely overvalued.
Cleaner valuation readings: PB 8.35x (2010-2026 range 0.91-8.9x, about the 94th percentile, close to the 2020 historical top); PS 11.27x (Japanese machinery sector about 0.9x, peer average 1.7-2.3x); EV/EBITDA 67.48x; Morningstar says the stock trades at about a 78% premium to fair value; SWS DCF fair value is ¥2,358.
Quantifying over-discounting: using a reasonable industrial-cycle floor valuation, reasonable PS or normalized 40x, implies a market cap of about ¥160.0-200.0 billion. Of the current market cap of about ¥671.2 billion, roughly 70%, or about ¥470.0-510.0 billion, is pure humanoid robot option value. To support the current price with a reasonable 40x multiple, normalized net income would need to reach about ¥16.8 billion, which is 2.5 times the historical peak of ¥6.6 billion. That means the humanoid business would need to grow into several times the size of the entire current company.
Downside calculations, current price ¥7,090:
| Method | Implied price (¥) | vs current price |
|---|---|---|
| SWS DCF fair value | 2,358 | -67% |
| Reasonable PS 2.7x × FY3/2026 revenue | about 1,700 | -76% |
| Reasonable PE 40.6x × guidance EPS ¥47.54 | about 1,930 | -73% |
| Reasonable PE 40.6x × consensus EPS ¥60.8 | about 2,468 | -65% |
| Sell-side average target, already including humanoid optimism | about 5,300 | -25% |
| Jefferies target | 2,400 | -66% |
【Valuation Range】(JPY): current price 7,090; bear 2,300-3,200 (cycle not recovered + humanoid upside goes elsewhere, reverting to DCF ¥2,358/52-week low ¥2,316/Jefferies ¥2,400); base 3,200-4,800 (normalized mid-cycle EPS about ¥70-85 × 45-55x + partial share retention, corresponding to the conservative end of sell-side targets); bull 6,000-9,500 (humanoid volume ramp + cycle recovery + share retention, challenging the 2020 historical high of ¥9,510). The current price is already inside the bull range, so the market is pricing today as if the humanoid supercycle succeeds.
【Ideal/Fair Buy Price】≤ ¥3,200. This is roughly normalized mid-cycle EPS of ¥70 × 45x, granting a premium for leadership plus humanoid optionality, but requiring a return to the upper end of a reasonable range. It is about a 55% drawdown from the current price and leaves a safety cushion for the cycle and Chinese substitution. Note: the sell-side average around ¥5,300 includes humanoid optimism, while the humanoid dividend may go to Chinese suppliers, so it is not used as a safe buying anchor.
10. Risks
【Very high】Valuation overreach: 417x/116-149x, PB 8.35x (about 94th percentile), PS 11.27x, with roughly 70% of market cap as a humanoid option; current price is above all sell-side averages, DCF points to -67%, Jefferies to -66%; current price equals about 101x historical peak earnings.
【High, structural】Humanoid dividend intercepted by Chinese suppliers: Tesla Optimus' main incremental harmonic reducer supply has gone to Leader Harmonious Drive (Mexico exclusive, about 10,000 sets delivered in 2025, target about 60%, 30-45% lower price), foundational patents have expired, and Goldman expects high-end robot share may trend toward "50-50" by 2030. Harmonic Drive Systems has not been cleared out and still defends high-end dual sourcing, but the issue is that the pie gets larger, its slice gets smaller, and gross margin is pressured.
【High】Domestic Chinese substitution + price war eroding share and gross margin: Leader's Suzhou/Mexico capacity is coming online; Harmonic Drive Systems' prices are 40-50% higher than domestic Chinese products, creating a dilemma between cutting prices and destroying gross margin or holding price and losing share.
【Medium-high】Cycle recovery not confirmed: utilization is only about 50%, FY3/2026 net income was -53.7%; FY3/2027 +141% guidance bets on semiconductor/automation recovery, not yet delivered, and sell-side consensus net income is still 28% above company guidance.
【Medium-high】Humanoid commercialization delays/technology substitution: Optimus has been delayed repeatedly, and Musk has described early output as "impossible to predict"; Agility Digit uses series elastic actuators plus cable drive, bypassing harmonic reducers and showing harmonics are not the only humanoid solution.
【Medium】Customer concentration + FX: core customers are a small number of highly cyclical OEMs such as FANUC/Yaskawa/ABB/UR; the company is export-oriented with JPY as reporting currency, so yen strength pressures profit. Precise overseas exposure was not obtained ⚠️.
【Currently low】Idle capacity/depreciation: there is no current over-expansion, with utilization at 50% and existing equipment sufficient. It becomes a major risk only if expansion based on humanoid expectations fails to materialize.
【Low】Governance/litigation: the company itself has no major litigation, financial defects, or governance scandal. The only visible litigation is that one auditor was named in a personal lawsuit related to his prior role as an outside director of JDI. It is unrelated to Harmonic Drive Systems' operations and should not be misrepresented as a company risk.
Pre-mortem, the most likely scenario for a large investment loss in 2-3 years, a Davis triple kill: ① earnings: Optimus ramp slips again and semiconductor/automation recovery fails to continue, causing the FY3/2027 "operating profit +141%" guidance to miss; ② share/gross margin: real high-volume humanoid demand is intercepted by Leader and other Chinese suppliers, forcing Harmonic Drive Systems to cut prices to defend share and dragging gross margin lower, so even a humanoid boom does not translate proportionally into Harmonic Drive Systems profit; ③ valuation: the market recognizes that the humanoid dividend went elsewhere and the cycle did not recover, so valuation reverts from 116-417x toward the industry-normal 15-40x range. Result: earnings and multiple contract together, sending the stock back toward ¥1,500-2,800 (-60%-80%), consistent with DCF ¥2,358 and the 52-week low of ¥2,316. Secondary scenario: the industry does well, but it is entirely a Chinese supplier victory. Harmonic Drive Systems becomes the right industry, wrong company; revenue grows moderately, but valuation slowly deflates over the long term as share is lost, down -40-60%.
11. Catalyst Tracking
Potential positive catalysts: FY3/2027 guidance delivery (operating profit +141%) / semiconductor equipment orders recovering and Japanese plant utilization rising steadily from about 50%, improving cost ratios / AI robot orders, about ¥2.5 billion, validating quarter by quarter toward more than doubling / Harmonic Drive Systems being specifically named as a mass-production nomination by Tesla/Figure/Boston Dynamics and others. Western humanoid customers are more likely incremental customers for it relative to Chinese systems / 2026-2030 medium-term plan execution.
Potential negative catalysts: Optimus mass production delayed again or initial output below expectations / Leader's Suzhou/Mexico capacity coming online and triggering a price war / renewed weakness in Chinese industrial/automotive demand / U.S. tariff policy, which the company lists as a risk.
Preset downgrade/upgrade triggers: if Optimus mass production slips, Leader is confirmed as the primary Optimus supplier, and cycle recovery stalls, downgrade to "Avoid"; if the stock corrects deeply below ¥3,200, operating earnings, measured by operating margin, continue to recover, and the company secures a Western humanoid mass-production nomination, upgrade to "Hold/Cautious Buy".
12. Zen Horizon Intersection
Vertical: Harmonic Drive Systems is a de facto standard-component manufacturer that introduced U.S. USM technology in 1970 and spent half a century becoming the global harmonic reducer leader. Revenue fluctuates sharply with the factory automation/semiconductor cycle, producing two peaks and two troughs. It is now in the early stage of recovery from a cycle trough, layered on the low base created by the 2024 one-off large impairment at the German subsidiary.
Horizontal: it is the world's only scaled pure harmonic reducer leader, with the highest humanoid purity, but forward 116x is the most expensive in the Japanese transmission chain. Nabtesco, the complementary RV twin leader rather than a threat, trades at only 28x and has better earnings quality. A-share Leader Harmonious Drive prices the same humanoid story with a market cap that has overtaken Harmonic Drive Systems and an even more extreme premium. The near-doubling of the whole chain over one year is theme beta.
Intersection conclusion: vertical "cycle-trough earnings" and horizontal "top valuation" stack into an extreme trough earnings × top valuation mismatch. The moat is real but eroding (3/5): broad in high-end markets, supported by materials/process know-how, high-end near exclusivity, and net cash, but structurally eaten away in mass production by half-price Chinese suppliers, while the largest growth dividend, humanoids, is likely to go to Leader. Rating ladder: Canaan (Avoid, bad business 2/5) < RXRX (Watch, unprofitable option 2.5/5) < Harmonic Drive Systems (Watch, bearish end, eroding moat 3/5) ≈ Fabrinet (Watch, narrow-moat contract manufacturer 3/5) < Cheniere/Siemens Energy (Hold, wide moat 4/5). Harmonic Drive Systems' quality, with global leadership + net cash + real profit history, is better than RXRX/Fabrinet, but valuation overreach is more extreme, with the current price above all sell-side averages and forward 116-149x. Therefore it sits at the bearish end of the "Watch" zone: a great company at an uninvestable price; wait for a deep correction of more than 40% before discussing it again.
Research Uncertainties
Large divergence in global share measurement ⚠️: value share is about 58%, high-end share is above 70%, GGII volume share is lower and declining, and China share is about 35.6%. There is no single authoritative conclusion. This report uses layered wording, while the trend, erosion by Chinese suppliers, is not disputed.
Two forward PE bases: 116.6x using consensus EPS of ¥60.8 versus 149x using company-guidance EPS of ¥47.54. This report does not average the two. Which one materializes depends on the recovery pace in automation, semiconductors, and humanoids; this report uses guidance as the prudent anchor.
Humanoid TAM and shipment forecasts diverge severely: 2026 humanoid shipment forecasts of 50,000 versus 900,000 units differ by one order of magnitude, and third-party harmonic TAM estimates differ by several times. Sensitivity is extremely high, so no single point estimate should be trusted.
Harmonic Drive Systems' confirmed humanoid share is unclear: current evidence points to Leader taking the main incremental Tesla supply, while Harmonic Drive Systems defends high-end dual sourcing and likely has more exposure to Western/Japanese OEMs. The exact "Harmonic Drive Systems content in Optimus" remains to be proven.
Precise overseas sales share was not obtained: many Japanese company disclosure sites returned 403 errors or PDF garbling, so FX risk can only be treated qualitatively.
FY3/2027 DPS of ¥42.1, more than 2 times higher, is a secondary-source reference and should be checked against the dividend-status section of the primary earnings release.
Price-layer data: Japanese .TSE coverage is limited across data sources, with EODHD whole-exchange access outside the package and real-time feeds prone to 404. All price/valuation data in this report come from stockanalysis plus multi-source cross-checks and reconcile with primary shares outstanding × stock price: 94.67M × ¥7,090 ≈ ¥671.2B market cap. The market-cap card on the site's /t/6324.TSE page may remain blank because price-layer coverage is unavailable; this does not affect the report conclusion.
Zen Horizon Framework research · Third-party review: key figures were independently red-teamed twice. Sell-side average target price, Jefferies rating, Tesla Optimus harmonic supply pattern, global share measurement basis, and forward PE basis were verified item by item. Share labels were finalized as "value share about 58%, high-end >70%." Entity disambiguation confirmed that Germany's SE is a wholly owned subsidiary, Nidec is not a shareholder, and KODEN is the parent company. This report does not constitute investment advice.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free